Just 15 years ago, prognosis for metastatic melanoma was grim with life expectancy of around six months. Thanks to breakthroughs, today survival rates can exceed 10 years.
Immunotherapy, introduced a decade ago, stimulates the body’s own defenses to fight cancer, radically changing the prognosis for patients with melanoma and several other cancers.
A recent study indicates almost half of metastatic melanoma patients treated with immunotherapy are cancer-free after ten years, showcasing the therapy's potential.
Experts highlight the necessity to identify optimal candidates for immunotherapy and explore combining it with other treatments to enhance efficacy, signaling the ongoing development in cancer therapy.
[
Collection
]
[
|
...
]